334 related articles for article (PubMed ID: 23948616)
1. Community-acquired pneumonia team decreases length of stay in hospitalized, low-risk patients with pneumonia.
Marcos PJ; Restrepo MI; Sanjuàn P; Ferreira-Gonzalez L; Verea-Hernando H
Hosp Pract (1995); 2013 Aug; 41(3):7-14. PubMed ID: 23948616
[TBL] [Abstract][Full Text] [Related]
2. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
[TBL] [Abstract][Full Text] [Related]
3. Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial.
Carratalà J; Garcia-Vidal C; Ortega L; Fernández-Sabé N; Clemente M; Albero G; López M; Castellsagué X; Dorca J; Verdaguer R; Martínez-Montauti J; Manresa F; Gudiol F
Arch Intern Med; 2012 Jun; 172(12):922-8. PubMed ID: 22732747
[TBL] [Abstract][Full Text] [Related]
4. Improved management of community-acquired pneumonia in the emergency department.
Julián-Jiménez A; Palomo de los Reyes MJ; Parejo Miguez R; Laín-Terés N; Cuena-Boy R; Lozano-Ancín A
Arch Bronconeumol; 2013 Jun; 49(6):230-40. PubMed ID: 23477946
[TBL] [Abstract][Full Text] [Related]
5. Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010-2018.
Kimura T; Ito M; Onozawa S
J Infect Chemother; 2020 Jul; 26(7):706-714. PubMed ID: 32284180
[TBL] [Abstract][Full Text] [Related]
6. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
[TBL] [Abstract][Full Text] [Related]
7. Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection.
Wongsurakiat P; Chitwarakorn N
BMC Pulm Med; 2019 Oct; 19(1):179. PubMed ID: 31619219
[TBL] [Abstract][Full Text] [Related]
8. Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.
Uranga A; España PP; Bilbao A; Quintana JM; Arriaga I; Intxausti M; Lobo JL; Tomás L; Camino J; Nuñez J; Capelastegui A
JAMA Intern Med; 2016 Sep; 176(9):1257-65. PubMed ID: 27455166
[TBL] [Abstract][Full Text] [Related]
9. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
Frei CR; Restrepo MI; Mortensen EM; Burgess DS
Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
[TBL] [Abstract][Full Text] [Related]
11. [Hospital admission, duration of stay and mortality in community-acquired pneumonia in an acute care hospital. Correlation between a pneumonia prognosis index and conventional clinical criteria for assessing severity].
Calbo E; Ochoa de Echagüen A; Rodríguez-Carballeira M; Ferrer C; Garau J
Enferm Infecc Microbiol Clin; 2004 Feb; 22(2):64-9. PubMed ID: 14756986
[TBL] [Abstract][Full Text] [Related]
12. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
[TBL] [Abstract][Full Text] [Related]
13. Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study.
Mahboub B; Al Zaabi A; Al Ali OM; Ahmed R; Niederman MS; El-Bishbishi R
BMC Pulm Med; 2015 Sep; 15():112. PubMed ID: 26424530
[TBL] [Abstract][Full Text] [Related]
14. Comparison of processes and outcomes of pneumonia care between hospitalists and community-based primary care physicians.
Rifkin WD; Conner D; Silver A; Eichorn A
Mayo Clin Proc; 2002 Oct; 77(10):1053-8. PubMed ID: 12374249
[TBL] [Abstract][Full Text] [Related]
15. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study.
DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L
Trials; 2015 Aug; 16():355. PubMed ID: 26272324
[TBL] [Abstract][Full Text] [Related]
16. A pharmacist-led prospective antibiotic stewardship intervention improves compliance to community-acquired pneumonia guidelines in 39 public and private hospitals across South Africa.
van den Bergh D; Messina AP; Goff DA; van Jaarsveld A; Coetzee R; de Wet Y; Bronkhorst E; Brink A; Mendelson M; Richards GA; Feldman C; Schellack N;
Int J Antimicrob Agents; 2020 Dec; 56(6):106189. PubMed ID: 33045348
[TBL] [Abstract][Full Text] [Related]
17. Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study.
Høgli JU; Garcia BH; Svendsen K; Skogen V; Småbrekke L
BMC Pulm Med; 2020 Jun; 20(1):169. PubMed ID: 32539706
[TBL] [Abstract][Full Text] [Related]
18. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
19. Community-acquired pneumonia: impact of empirical antibiotic therapy without respiratory fluoroquinolones nor third-generation cephalosporins.
Pradelli J; Risso K; de Salvador FG; Cua E; Ruimy R; Roger PM
Eur J Clin Microbiol Infect Dis; 2015 Mar; 34(3):511-8. PubMed ID: 25273975
[TBL] [Abstract][Full Text] [Related]
20. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
Lee RW; Lindstrom ST
Respirology; 2007 Jan; 12(1):111-6. PubMed ID: 17207035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
